相关实验视频
Updated: Sep 17, 2025

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
775
孕期糖尿病和心力衰竭:一个系统的审查和元分析
Eric K Broni1, Sebhat Erqou2, Ravi Retnakaran3
1Pregnancy and Perinatal Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
JACC. Advances
|June 27, 2025
概括
孕期糖尿病 (GDM) 显著增加心力衰竭 (HF) 的风险. 这一元分析证实了GDM作为一个独立的风险因素,强调了需要HF预防策略.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 生殖健康 生殖健康
背景情况:
- 孕期糖尿病 (GDM) 和心力衰竭 (HF) 发生率之间的关系需要进一步澄清.
- 目前关于GDM对长期心血管健康的影响,特别是HF风险的影响的证据有限.
研究的目的:
- 系统地审查和元分析现有的队列研究,调查GDM与患高风险之间的关联.
- 量化具有GDM病史的个体中HF风险.
主要方法:
- 对队列研究进行系统审查和元分析.
- 在PubMed和Embase数据库中搜索到2024年7月24日之前的相关研究.
- 采用随机效应模型进行聚合调整的相对风险 (RR) 估计.
主要成果:
- 对8项涉及超过630万参与者的研究分析显示,在患有GDM的个体中,HF的聚合调整后RR为1.54 (95% CI: 1.24-1.92).
- 这种关联尽管在研究中存在异质性 (I2 = 86.9%),但仍然显著.
- 敏感性分析证实了这些发现的可靠性.
结论:
- 孕期糖尿病独立地与心力衰竭的风险增加有关.
- GDM可能在不良的心肌重塑中起因作用,这表明它应该是预防心力衰竭的关键考虑因素.
- 医疗保健提供者应该考虑GDM史作为未来HF发展的重要风险因素.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation
41
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
41
Heart Failure II: Pathophysiology
54
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
54
Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309
Heart Failure I: Introduction
75
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
75

